Nanoform logo Nanoform logo
Loading..
Loading..
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Investerarkalender

2020
  • Kommande händelser
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • Alla år
7 april, 2020

Årsstämma 2020

29 juli - 27 augusti, 2020

Tyst period

28 August, 2020, kl 08:10 EEST

Halvårsrapport, januari-juni 2020

17 november - 18 november, 2020

Jefferies Virtual Healthcare Conference, London

18 november, 2020

Nanoform to present at Avanza Börsdag on November 18th

25 november, 2020

Nordea Innovation Seminar, Stockholm

27 november, 2020

Delårsrapport, januari-september 2020

9 december, 2020

Danske Bank Global Telekonferens för Institutionella Investerare

December 12, 2020 kl 21.30 EEST/20.30 CEST

Nanoform presenteras på Advancements TV med Ted Danson på nyhets kanalen CNBC

Kontakta oss

+358 29 370 0150
info@nanoform.com

  • Persondata
  • Cookies

Prenumerera

Läs mer om hur vi skyddar dina personuppgifter.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Organisationsnummer: 2730572-8